Liven Pharma Ltd
PPSX:LIVEN30.50
PKR
-0.01
(-0.03%)
Liven Pharma Ltd
PSX:LIVEN
(Pakistan Stock Exchange)
Recent
price
30.50
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Liven Pharma Ltd is a Pakistan-based pharmaceutical company engaged in the development, manufacturing, marketing, and distribution of a broad portfolio of generic pharmaceuticals, therapeutic formulations, nutraceuticals, and healthcare products. The company operates primarily through its Pharmaceutical Formulations, Consumer Healthcare, and Contract Manufacturing segments. Its product portfolio spans diverse dosage forms, including solid orals such as immediate-release tablets, sustained-release tablets, chewable tablets, and hard and soft gelatin capsules; liquid orals comprising pediatric syrups, oral suspensions, elixirs, and drops; parenteral and sterile injectables encompassing lyophilized powders, ampoules, vials, and infusion solutions; topical preparations including medicated creams, ointments, lotions, and dermatological gels; and specialized delivery systems such as sterile ophthalmic drops, ear drops, and nasal sprays. The company offers medicinal products across several core therapeutic categories, including anti-infective and antibacterial agents; cardiovascular and antihypertensive medications; gastrointestinal and anti-ulcer treatments; analgesics, antipyretics, and non-steroidal anti-inflammatory drugs; central nervous system agents; respiratory and antihistaminic drugs; endocrine and anti-diabetic formulations; and dietary supplements, multivitamins, and minerals. In addition to branded generics, the company provides toll manufacturing, formulation development, packaging, and quality control testing services for institutional clients, multinational partners, and third-party healthcare organizations. In recent developments, Liven Pharma Ltd has executed strategic corporate restructuring and operational realignment initiatives to strengthen its commercial footprint and listing profile on the Pakistan Stock Exchange. The company has completed facility upgrades and modernization programs across its manufacturing and quality assurance laboratories to enhance production capacity and maintain strict compliance with current Good Manufacturing Practice standards mandated by the Drug Regulatory Authority of Pakistan. To accelerate revenue growth and diversify its revenue base, Liven Pharma Ltd has expanded its product pipeline with new launches in high-demand chronic disease segments, specialized cardiology formulations, and preventive wellness supplements. The company has also established strategic supply and distribution agreements with leading national pharmaceutical logistics networks to expand pharmacy shelf presence across Pakistan, while pursuing regulatory filings and partner alliances to facilitate export market penetration across South Asia, Central Asia, the Middle East, and Africa. Founded in Pakistan and headquartered in Karachi, Pakistan, Liven Pharma Ltd serves retail pharmacies, medical clinics, private hospital networks, and public healthcare institutions nationwide.